169 related articles for article (PubMed ID: 29511597)
1. AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.
Wu Q; Yang ZF; Wang KJ; Feng XY; Lv ZJ; Li Y; Jian ZX
Am J Cancer Res; 2018; 8(2):266-279. PubMed ID: 29511597
[TBL] [Abstract][Full Text] [Related]
2. Identification of the AQP8-miR-92a network associated with the aggressive traits of colorectal cancer.
Zhang H; Du WB; Guo XM; Wang LK; Cheng JM; Wei LJ
Biochem Biophys Res Commun; 2020 Jun; 527(1):218-225. PubMed ID: 32446370
[TBL] [Abstract][Full Text] [Related]
3. SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.
Tiwari R; Pandey SK; Goel S; Bhatia V; Shukla S; Jing X; Dhanasekaran SM; Ateeq B
Oncogenesis; 2015 Aug; 4(8):e162. PubMed ID: 26258891
[TBL] [Abstract][Full Text] [Related]
4. The roles of protocadherin-7 in colorectal cancer cells on cell proliferation and its chemoresistance.
Zheng Z; Luan N; Tu K; Liu F; Wang J; Sun J
Front Pharmacol; 2023; 14():1072033. PubMed ID: 37063257
[TBL] [Abstract][Full Text] [Related]
5. RING finger protein 128 (RNF128) regulates malignant biological behaviors of colorectal cancer cells via PI3K/AKT signaling pathway.
Zhuang Y; Liu PF; Zhan Y; Kong DL; Tian F; Zhao P
Cell Biol Int; 2022 Oct; 46(10):1604-1611. PubMed ID: 35723244
[TBL] [Abstract][Full Text] [Related]
6. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
7. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.
Song Y; Zhao Y; Ding X; Wang X
Am J Cancer Res; 2018; 8(3):435-449. PubMed ID: 29636999
[TBL] [Abstract][Full Text] [Related]
8. Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis.
Cao JZ; Ma LM; Zhang YL; Guo HC; Niu X; Zhao TB
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4730-4737. PubMed ID: 31210299
[TBL] [Abstract][Full Text] [Related]
9. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.
Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H
Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743
[TBL] [Abstract][Full Text] [Related]
10. ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.
Wu M; Li R; Qin J; Wang Z; Guo J; Lv F; Wang G; Huang Y
J Mol Histol; 2023 Dec; 54(6):621-631. PubMed ID: 37776473
[TBL] [Abstract][Full Text] [Related]
11. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway.
Li J; Jiang JL; Chen YM; Lu WQ
J Pathol Clin Res; 2023 Sep; 9(5):423-435. PubMed ID: 37147883
[TBL] [Abstract][Full Text] [Related]
12. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
14. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
15. Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway.
Li T; Si W; Zhu J; Yin L; Zhong C
Am J Transl Res; 2020; 12(5):1851-1861. PubMed ID: 32509181
[TBL] [Abstract][Full Text] [Related]
16. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
17. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
18. Yiqi Huayu Jiedu Decoction inhibits liver metastasis of colorectal cancer via enhancing natural killer cells function.
Zhou JY; Wu C; Shen Z; Liu S; Zou X; Qian J; Wu Z; Huan X; Mu BX; Ye N; Ning Y; Wang Y; Chen M; Zhuang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116915. PubMed ID: 37451487
[TBL] [Abstract][Full Text] [Related]
19. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
20. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
